ICRAV Melbourne 2026

295 ICRAV 2026 POSTER SESSION # Poster Title Author 34 Metabolism and Detection of Ertugliflozin in the Equine Marjaana Viljanto 35 A Non-Animal Apparatus for Investigating Longitudinal Absorption From the Small Intestine in Complex Matrices Paul Wynne 36 ‘Dogabolics II’ Project–An Update on Prostanozol, Mechabol, Turinabol and Finaflex 1-andro Sean Yamada 37 Impact of Blood Collection Tubes on Drug Detection in Equine Doping Analysis Youwen You 38 Effects of Intra-articular Polyacrylamide Hydrogel on Equine Nerves and Macrophage Responses Simon R Bailey 39 Exploring Medication Practices: Current Approaches of Trainers and Veterinarians to the Medication of Victorian Thoroughbred Racehorses Hilary SA Colwell 40 Systemic Exposure of Timolol After Topical Administration to Horses: A Pilot Study Carl Ekstrand 42 Analysis of Hydrocortisone Acetate in Horse Urine and Plasma Following Topical Administration a Pilot Study Marjaana Viljanto 43 Exercise Associated Sudden Death at Horseracing Safety & Integrity Authority Covered Racetracks July 1 2022 Through June 29 2025 Karen A Hassan 44 RNA Sequencing Reveals Possible Biomarkers of Fetlock Injury in Racehorses Joanne E Haughan 45 Co-administration of Furosemide and Clodronate Affect Serum Ionized Calcium and Parathyroid Hormone Levels as well as Circulating Biomarkers of Bone Turnover in Young, Exercising Thoroughbreds. Joanne E Haughan 46 ISO 9001-2015 Certification: A Major Challenge in the World of Veterinary Horse Racing Victoria VH Hernandez 47 IHRB Veterinary Authorised Officers: Challenges and Successes Lynn Hillyer 48 Wearable Technology for Cardiac Monitoring in Exercising Horses: Review of Current Technologies and Emerging Research Amie E Kapusniak 49 Red Blood Cell Sequestration Contributes to the Prolonged Residence Time of Metformin in Horses Heather K Knych 50 Digital Innovation in Animal Welfare Regulation  Tony Kuipers 51 Exercise-Associated Sudden Death in Racing Greyhounds: Incidence and Post-Mortem Findings Across Australasia Steven Karamatic # Poster Title Author 52 Rabies Surveillance and Dog Population Management: Insights From a Survey of Roaming Dogs in Qatar 2024 Mahmoud Mohamed 53 Pharmacokinetics and Effects of Isoflupredone on Plasma Electrolytes and Fractional Excretion After a Single Intramuscular Administration in Horses Camilo Morales 54 Managing Ketoprofen Residues in Meat Fed to Racing Greyhounds Tim Morris 55 Urinary Excretion of Tiludronic Acid Following an Intravenous Infusion of Tildren® to Horses Glenys K Noble 56 Determination of the Pharmacokinetics of Triamcinolone Acetonide Administered Intra-articularly to the Femoropatellar Joint of the Horse Glenys K Noble 57 Pharmacokinetics of Clenbuterol Hydrochloride, Salbutamol Plus Ipratropium Bromide Administered by Nebuliser to Horses Glenys K Noble 58 Modelling the Impact of Training Practices on Subchondral Bone Adaptation and Microdamage in Racehorses Michael Pan 59 Are Pre-and Post-Race Veterinary Examinations Necessary? Evidence From the Qatar Racing Industry Michelle M Pap 60 Objective Lameness Assessment on Jeju Horses Using a Body Mounted Inertial Sensor System HeeEun SONG 61 ISO9001 Quality Management Certification in Hipódromo Chile Test Barn: Enhancing Integrity in Equine Doping Control in Chile Paula SozaOssandón 62 A Review of the Regulatory Process and Outcomes for Permanently Retired Horses Reinstated to Racing in GB From 2020-2025 Lucinda J Tyler 64 Size Exclusion Chromatographic (SEC) Method for Oligonucleotides Using Heated Columns Namrata Saxena 65 A Novel Screening Workflow for the Detection of Drugs in Hair Paul Zahra 66 A Tale of Two Peaks: Tautomers of Phenylbutazone and Associated Analytical Challenges in Regulatory Testing Buddhika N Dorakumbura 67 A Sandwich ELISA for the Detection of CJC1295 in Equine Plasma Mark Timms 68 Detection of Formestane, 4-Hydroxytestosterone, and 6α-Hydroxyandrostenedione in a Female Thoroughbred Racehorse in Chile: Analytical Findings, Origin Hypotheses, and Regulatory Collaboration Paula SozaOssandón

RkJQdWJsaXNoZXIy MTI3ODI1